Literature DB >> 22281385

Postembolization perianeurysmal edema as a cause of uncinate seizures.

José E Cohen1, Eyal Itshayek, Moshe Attia, Samuel Moscovici.   

Abstract

We report a patient with a giant unruptured supraclinoid aneurysm treated by endovascular embolization by means of bare coils and implantation of a flow diverterstent. Eight weeks after the embolization, she presented with uncinate seizures. Neuroradiological examination revealed de novo postembolization perianeurysmal edema, which has been described only rarely. A brief course of oral steroids successfully controlled the seizures. Perianeurysmal edema must be considered a potential complication after embolization of large aneurysms with coils and other means, and needs to be considered as a differential diagnosis in patients with unusual neurological symptoms at either the acute or delayed stages. To our knowledge, this is the first report of postembolization perianeurysmal edema occurring after successful occlusion by means of bare coils and a flow diverterstent. This report contributes to the growing evidence on adverse post-coiling inflammatory reactions, and specifically on perianeurysmal edema.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281385     DOI: 10.1016/j.jocn.2011.08.008

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  2 in total

1.  Late occurrence of a symptomatic perianeurysmal edema and wall enhancement after coil embolization.

Authors:  Madjidyar Jawid; Brandt Ulrike; Binder Andreas; Jansen Olav
Journal:  Neuroradiology       Date:  2014-08-10       Impact factor: 2.804

2.  Analysis of risk factors for perifocal oedema after endovascular embolization of unruptured intracranial arterial aneurysms.

Authors:  Snezana Lukic; Slobodan Jankovic; Katarina Surlan Popovic; Dragic Bankovic; Peter Popovic; Milan Mijailovic
Journal:  Radiol Oncol       Date:  2015-11-27       Impact factor: 2.991

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.